Dopamine D(2) receptor function is compromised in the brain of the methionine sulfoxide reductase A knockout mouse.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 2933736)

Published in J Neurochem on March 31, 2010

Authors

Derek B Oien1, Andrea N Ortiz, Alexander G Rittel, Rick T Dobrowsky, Michael A Johnson, Beth Levant, Stephen C Fowler, Jackob Moskovitz

Author Affiliations

1: Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, Kansas 66045, USA.

Articles cited by this

Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci U S A (2001) 3.62

Escherichia coli peptide methionine sulfoxide reductase gene: regulation of expression and role in protecting against oxidative damage. J Bacteriol (1995) 3.41

The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo. Proc Natl Acad Sci U S A (1997) 3.05

High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc Natl Acad Sci U S A (2002) 2.85

Distinct functions of the two isoforms of dopamine D2 receptors. Nature (2000) 2.83

Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress. Proc Natl Acad Sci U S A (1998) 2.19

Coupling oxidative signals to protein phosphorylation via methionine oxidation in Arabidopsis. Biochem J (2009) 1.97

Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl (1998) 1.92

Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases. Biochim Biophys Acta (2005) 1.90

A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Methods (2001) 1.86

Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J Neurosci (2000) 1.49

The [35S]GTPgammaS binding assay: approaches and applications in pharmacology. Life Sci (2003) 1.47

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev (2008) 1.46

Substrates of the methionine sulfoxide reductase system and their physiological relevance. Curr Top Dev Biol (2008) 1.31

Radioligand binding methods: practical guide and tips. Am J Physiol (1993) 1.29

Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease. J Neurochem (2006) 1.29

G protein-coupled receptor kinase-mediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor. J Biol Chem (2009) 1.27

Investigations into the role of the plastidial peptide methionine sulfoxide reductase in response to oxidative stress in Arabidopsis. Plant Physiol (2004) 1.27

Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse. Exp Brain Res (2007) 1.21

The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease. J Neurochem (2002) 1.13

Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain. J Pharmacol Exp Ther (1992) 1.08

MsrA knockout mouse exhibits abnormal behavior and brain dopamine levels. Free Radic Biol Med (2008) 1.08

Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production. J Proteome Res (2010) 1.08

Preferential coupling between dopamine D2 receptors and G-proteins. Mol Endocrinol (1993) 1.03

Methionine sulfoxide reductase: a novel schizophrenia candidate gene. Am J Med Genet B Neuropsychiatr Genet (2009) 1.00

A dopamine D2 receptor mutant capable of G protein-mediated signaling but deficient in arrestin binding. Mol Pharmacol (2008) 0.99

In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid. Neuroscience (2009) 0.98

[Dopamine (3-hydroxytyramine) in the central nervous system and its relation to the Parkinson syndrome in man]. Dtsch Med Wochenschr (1962) 0.95

Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells. J Mol Neurosci (2009) 0.93

Coupling of dopamine receptors to G proteins: studies with chimeric D2/D3 dopamine receptors. Cell Mol Neurobiol (2002) 0.88

Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function. BMC Neurosci (2009) 0.87

Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists. J Pharmacol Exp Ther (1997) 0.86

Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats. Behav Brain Res (1991) 0.85

Restoration of the striatal dopamine synthesis for Parkinson's disease: viral vector-mediated enzyme replacement strategy. Curr Gene Ther (2007) 0.85

Oxidation of methionine residues: the missing link between stress and signalling responses in plants. Biochem J (2009) 0.84

Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation. J Neurosci (2001) 0.82

Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow. Neuropharmacology (2003) 0.80

Ropinirole therapy for Parkinson's disease. Expert Rev Neurother (2004) 0.79

Blockade of neurokinin-3 receptors modulates dopamine-mediated behavioral hyperactivity. Neuropharmacology (2009) 0.79

Age dependence of motor activity and sensitivity to dopamine receptor 1 agonist, SKF82958, of inbred AKR/J, BALB/c, C57BL/6J, SAMR1, and SAMP6 strains. Brain Res (2008) 0.78

Articles by these authors

Resolving neurotransmitters detected by fast-scan cyclic voltammetry. Anal Chem (2004) 3.18

A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem (2003) 2.69

Oxidation of methionine residues of proteins: biological consequences. Antioxid Redox Signal (2003) 1.88

Reduced sensitivity of influenza A (H5N1) to oseltamivir. Emerg Infect Dis (2007) 1.81

Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. Infect Immun (2003) 1.67

Modulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathy. Exp Neurol (2012) 1.59

Genes contributing to prion pathogenesis. J Gen Virol (2008) 1.51

Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism. Mol Cell Biochem (2002) 1.51

Substrates of the methionine sulfoxide reductase system and their physiological relevance. Curr Top Dev Biol (2008) 1.31

Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach. J Med Chem (2003) 1.30

Detection of oxidized methionine in selected proteins, cellular extracts and blood serums by novel anti-methionine sulfoxide antibodies. Arch Biochem Biophys (2009) 1.29

Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse. Exp Brain Res (2007) 1.21

Ceramide displaces cholesterol from lipid rafts and decreases the association of the cholesterol binding protein caveolin-1. J Lipid Res (2005) 1.21

Inhibiting heat-shock protein 90 reverses sensory hypoalgesia in diabetic mice. ASN Neuro (2010) 1.21

Multiple methionine sulfoxide reductase genes in Staphylococcus aureus: expression of activity and roles in tolerance of oxidative stress. Microbiology (2003) 1.20

Diminished superoxide generation is associated with respiratory chain dysfunction and changes in the mitochondrial proteome of sensory neurons from diabetic rats. Diabetes (2010) 1.18

Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity. Psychopharmacology (Berl) (2011) 1.18

Bone marrow transplantation augments the effect of brain- and spinal cord-directed adeno-associated virus 2/5 gene therapy by altering inflammation in the murine model of globoid-cell leukodystrophy. J Neurosci (2011) 1.12

Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease. J Neurosci (2009) 1.11

S-nitrosothiol depletion in amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2006) 1.11

In-vivo electrochemistry: what can we learn about living systems? Chem Rev (2008) 1.11

IkappaB is a sensitive target for oxidation by cell-permeable chloramines: inhibition of NF-kappaB activity by glycine chloramine through methionine oxidation. Biochem J (2006) 1.10

Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum. J Neurochem (2009) 1.10

MsrA knockout mouse exhibits abnormal behavior and brain dopamine levels. Free Radic Biol Med (2008) 1.08

Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production. J Proteome Res (2010) 1.08

DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconjug Chem (2002) 1.07

Oxidation of Helix-3 methionines precedes the formation of PK resistant PrP. PLoS Pathog (2010) 1.06

Mouse methionine sulfoxide reductase B: effect of selenocysteine incorporation on its activity and expression of the seleno-containing enzyme in bacterial and mammalian cells. Biochem Biophys Res Commun (2002) 1.04

Allele-dependent changes of olivocerebellar circuit properties in the absence of the voltage-gated potassium channels Kv3.1 and Kv3.3. Eur J Neurosci (2004) 1.03

Relative bioavailability of calcium from calcium formate, calcium citrate, and calcium carbonate. J Pharmacol Exp Ther (2005) 1.02

Force-plate quantification of progressive behavioral deficits in the R6/2 mouse model of Huntington's disease. Behav Brain Res (2009) 0.99

Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach? Pharmacol Rev (2012) 0.99

Biological activity of the tryprostatins and their diastereomers on human carcinoma cell lines. J Med Chem (2002) 0.98

Hyperglycemia and downregulation of caveolin-1 enhance neuregulin-induced demyelination. Glia (2008) 0.98

Caveolin-1 and altered neuregulin signaling contribute to the pathophysiological progression of diabetic peripheral neuropathy. Diabetes (2009) 0.98

Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons. J Neurochem (2003) 0.98

Household light makes global heat: high black carbon emissions from kerosene wick lamps. Environ Sci Technol (2012) 0.97

Antibodies against methionine sulfoxide of proteins. Free Radic Biol Med (2013) 0.97

Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetes. Mitochondrion (2011) 0.96

C-terminal heat shock protein 90 inhibitor decreases hyperglycemia-induced oxidative stress and improves mitochondrial bioenergetics in sensory neurons. J Proteome Res (2012) 0.96

Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis. Cancer Res (2005) 0.96

Suppression of the TNFalpha-induced increase in IL-1alpha expression by hypochlorite in human corneal epithelial cells. Invest Ophthalmol Vis Sci (2002) 0.95

Aged Fischer 344 rats exhibit altered orolingual motor function: relationships with nigrostriatal neurochemical measures. Neurobiol Aging (2002) 0.94

Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile. J Med Chem (2008) 0.93

Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells. J Mol Neurosci (2009) 0.93

Maternal parity and diet (n-3) polyunsaturated fatty acid concentration influence accretion of brain phospholipid docosahexaenoic acid in developing rats. J Nutr (2007) 0.91

Differential acquisition of lever pressing in inbred and outbred mice: comparison of one-lever and two-lever procedures and correlation with differences in locomotor activity. J Exp Anal Behav (2005) 0.91

Effects of pramipexole on impulsive choice in male wistar rats. Exp Clin Psychopharmacol (2010) 0.90

A low-cost particle counter as a realtime fine-particle mass monitor. Environ Sci Process Impacts (2012) 0.90

Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: a stereological study. Neurosci Lett (2008) 0.88

Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonists. J Med Chem (2014) 0.88

Differential acquisition of food-reinforced disk pressing by CD-1, BALB/cJ and C57BL/6J mice. Behav Brain Res (2004) 0.88

Developmental effects of dietary n-3 fatty acids on activity and response to novelty. Physiol Behav (2010) 0.88

Tau neurofibrillary pathology and microtubule stability. J Mol Neurosci (2002) 0.88

An inexpensive infrared detector to verify the delivery of food pellets. J Exp Anal Behav (2008) 0.87

Demonstration of functional coupling between dopamine synthesis and its packaging into synaptic vesicles. J Biomed Sci (2003) 0.87

Effects of acute pramipexole on preference for gambling-like schedules of reinforcement in rats. Psychopharmacology (Berl) (2010) 0.87

Heat shock protein 70 is necessary to improve mitochondrial bioenergetics and reverse diabetic sensory neuropathy following KU-32 therapy. J Pharmacol Exp Ther (2013) 0.87

Signaling mechanisms of the D3 dopamine receptor. J Recept Signal Transduct Res (2004) 0.87

Ablation of the mammalian methionine sulfoxide reductase A affects the expression level of cysteine deoxygenase. Biochem Biophys Res Commun (2006) 0.87

Fluorogenic Tagging of Peptide and Protein 3-Nitrotyrosine with 4-(Aminomethyl)-benzenesulfonic Acid for Quantitative Analysis of Protein Tyrosine Nitration. Chromatographia (2010) 0.87

Porcine adenovirus as a delivery system for swine vaccines and immunotherapeutics. Vet J (2005) 0.87

Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration. Neuropsychopharmacology (2003) 0.86

Synthesis and evaluation of novologues as C-terminal Hsp90 inhibitors with cytoprotective activity against sensory neuron glucotoxicity. J Med Chem (2012) 0.86

Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis. PLoS Genet (2012) 0.86

Within-session analysis of amphetamine-elicited rotation behavior reveals differences between young adult and middle-aged F344/BN rats with partial unilateral striatal dopamine depletion. Pharmacol Biochem Behav (2010) 0.86

Methionine-centered redox cycle in organs of the aero-digestive tract of young and old rats. Biogerontology (2008) 0.86

Dopamine receptor alterations in female rats with diet-induced decreased brain docosahexaenoic acid (DHA): interactions with reproductive status. Nutr Neurosci (2010) 0.86

Long-term Effects of Multiple Glucocorticoid Exposures in Neonatal Mice. Behav Sci (Basel) (2011) 0.85

Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease. Neurobiol Dis (2009) 0.85

Impaired dopamine release and uptake in R6/1 Huntington's disease model mice. Neurosci Lett (2011) 0.85

The neuroimmunophilin GPI-1046 partially protects against 3-acetylpyridine toxicity in the rat. Neurosci Lett (2002) 0.84

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist. ACS Med Chem Lett (2011) 0.84

A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study. J Neurosci Methods (2012) 0.84

The role of exogenous testosterone in cocaine-induced behavioral sensitization and plasmalemmal or vesicular dopamine uptake in castrated rats. Neurosci Lett (2003) 0.84

Differences in quinpirole-induced local cerebral glucose utilization between naive and sensitized rats. Brain Res (2003) 0.83

The Role of Methionine Oxidation/Reduction in the Regulation of Immune Response. Curr Signal Transduct Ther (2009) 0.83

Measuring forelimb force control and movement in Fischer 344/Brown Norway rats: effects of age and lorazepam. Behav Pharmacol (2006) 0.83

Absorption and elimination of formate following oral administration of calcium formate in female human subjects. Drug Metab Dispos (2004) 0.83

Hsp90 C-terminal inhibitors exhibit antimigratory activity by disrupting the Hsp90α/Aha1 complex in PC3-MM2 cells. ACS Chem Biol (2014) 0.83

Decreased activity and enhanced nuclear export of CCAAT-enhancer-binding protein beta during inhibition of adipogenesis by ceramide. Biochem J (2002) 0.83

Peptide methionine sulfoxide reductase (MsrA) is not a major virulence determinant for the oral pathogen Actinobacillus actinomycetemcomitans. Microbiology (2002) 0.83

A homologue of elongation factor 1 gamma regulates methionine sulfoxide reductase A gene expression in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2003) 0.82

Dopamine Release and Uptake Impairments and Behavioral Alterations Observed in Mice that Model Fragile X Mental Retardation Syndrome. ACS Chem Neurosci (2010) 0.82

Sensorimotor behavioral tests for use in a juvenile rat model of traumatic brain injury: assessment of sex differences. J Neurosci Methods (2011) 0.82

Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligands. Bioorg Med Chem Lett (2005) 0.82

Aged Fischer 344 rats exhibit altered locomotion in the absence of decreased locomotor activity: exacerbation by nomifensine. Neurosci Lett (2002) 0.82

Decreased Phosphorylation and Increased Methionine Oxidation of α-Synuclein in the Methionine Sulfoxide Reductase A Knockout Mouse. J Amino Acids (2011) 0.82

Novel animal pole-enriched maternal mRNAs are preferentially expressed in neural ectoderm. Dev Dyn (2013) 0.82

Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations. Dement Geriatr Cogn Disord (2012) 0.82

Protection of pigs against 'in contact' challenge with classical swine fever following oral or subcutaneous vaccination with a recombinant porcine adenovirus. Virus Res (2003) 0.81

Differential sensitivity of cranial and limb motor function to nigrostriatal dopamine depletion. Behav Brain Res (2012) 0.81

Design of novel hexahydropyrazinoquinolines as potent and selective dopamine D3 receptor ligands with improved solubility. Bioorg Med Chem Lett (2005) 0.81

Induction of heat shock protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun. ASN Neuro (2012) 0.81

Bone Marrow Transplantation Alters the Tremor Phenotype in the Murine Model of Globoid-Cell Leukodystrophy. J Clin Med (2012) 0.81